{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:16:18Z","timestamp":1792617378931,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002332","name":"Semmelweis University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002332","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-47296-x","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:27:27Z","timestamp":1777530447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The gut mycobiome and inter-kingdom microbial networks are linked to COPD severity in lung cancer patients"],"prefix":"10.1038","volume":"16","author":[{"given":"Gy\u00f6rgy","family":"Szklenarik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e1ra","family":"Szincsak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement Kojo","family":"Acquah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arghajit","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1ty\u00e1s","family":"Horv\u00e1th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Galffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Lohinai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"47296_CR1","doi-asserted-by":"publisher","first-page":"e2346598","DOI":"10.1001\/jamanetworkopen.2023.46598","volume":"6","author":"E Boers","year":"2023","unstructured":"Boers, E. et al. Global burden of chronic obstructive pulmonary disease through 2050. JAMA Netw. Open. 6, e2346598 (2023).","journal-title":"JAMA Netw. Open."},{"issue":"25","key":"47296_CR2","first-page":"434","volume":"120","author":"K Kahnert","year":"2023","unstructured":"Kahnert, K. et al. The diagnosis and treatment of COPD and its comorbidities. Dtsch. Arztebl Int. 120 (25), 434\u2013444 (2023).","journal-title":"Dtsch. Arztebl Int."},{"issue":"5","key":"47296_CR3","doi-asserted-by":"publisher","first-page":"L879","DOI":"10.1152\/ajplung.00429.2020","volume":"319","author":"A Agust\u00ed","year":"2020","unstructured":"Agust\u00ed, A., Vogelmeier, C. & Faner, R. Copd 2020: changes and challenges. Am. J. Physiol. Lung Cell. Mol. Physiol. 319 (5), L879\u2013L883. https:\/\/doi.org\/10.1152\/ajplung.00429.2020 (2020). Epub 2020\/09\/24.","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"6","key":"47296_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/01.NPR.0000000000000180","volume":"49","author":"NMS Patel","year":"2024","unstructured":"Patel, N. M. S. & FNP-C, M. S. N. APRN PHN. An update on COPD prevention, diagnosis, and management: The 2024 GOLD Report. Nurse Pract. 49 (6), 29\u201336 (2024).","journal-title":"Nurse Pract."},{"key":"47296_CR5","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1016\/S0140-6736(22)00470-6)","volume":"399","author":"SA Christenson","year":"2022","unstructured":"Christenson, S. A., Smith, B. M., Bafadhel, M. & Putcha, N. Chronic obstructive pulmonary disease. Lancet 399, 2227\u20132242. https:\/\/doi.org\/10.1016\/S0140-6736(22)00470-6) (2022).","journal-title":"Lancet"},{"key":"47296_CR6","doi-asserted-by":"publisher","unstructured":"Dora, D. et al. From bench to bedside: an interdisciplinary journey through the gut-lung axis with insights into lung cancer and immunotherapy. Front. Immunol. 2024 Sep. 5. 15:1434804. https:\/\/doi.org\/10.3389\/fimmu.2024.1434804. PMID: 39301033; PMCID: PMC11410641.","DOI":"10.3389\/fimmu.2024.1434804"},{"issue":"1","key":"47296_CR7","doi-asserted-by":"publisher","first-page":"5886","DOI":"10.1038\/s41467-020-19701-0","volume":"11","author":"KL Bowerman","year":"2020","unstructured":"Bowerman, K. L. et al. Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease. Nat. Commun. 11 (1), 5886. https:\/\/doi.org\/10.1038\/s41467-020-19701-0 (2020).","journal-title":"Nat. Commun."},{"key":"47296_CR8","doi-asserted-by":"publisher","first-page":"1042189","DOI":"10.3389\/fphar.2022.1042189","volume":"13","author":"S Rastogi","year":"2022","unstructured":"Rastogi, S. & Singh, A. Gut microbiome and human health: Exploring how the probiotic genus Lactobacillus modulate immune responses. Front. Pharmacol. 13, 1042189. https:\/\/doi.org\/10.3389\/fphar.2022.1042189 (2022).","journal-title":"Front. Pharmacol."},{"key":"47296_CR9","doi-asserted-by":"publisher","first-page":"110231","DOI":"10.1016\/j.cbi.2022.110231","volume":"368","author":"S Ashique","year":"2022","unstructured":"Ashique, S. et al. Short chain fatty acids: fundamental mediators of the gut\u2013lung axis and their involvement in pulmonary diseases. Chem. Biol. Interact. 368, 110231. https:\/\/doi.org\/10.1016\/j.cbi.2022.110231 (2022).","journal-title":"Chem. Biol. Interact."},{"issue":"9","key":"47296_CR10","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1164\/rccm.202206-1066TR","volume":"207","author":"L Wang","year":"2023","unstructured":"Wang, L. et al. The bidirectional gut\u2013lung axis in chronic obstructive pulmonary disease. Am. J. Respir Crit. Care Med. 207 (9), 1145\u20131160. https:\/\/doi.org\/10.1164\/rccm.202206-1066TR (2023).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"47296_CR11","doi-asserted-by":"publisher","first-page":"1358597","DOI":"10.3389\/fmicb.2024.1358597","volume":"15","author":"M Sun","year":"2024","unstructured":"Sun, M. et al. Respiratory diseases and gut microbiota: relevance, pathogenesis, and treatment. Front. Microbiol. 15, 1358597. https:\/\/doi.org\/10.3389\/fmicb.2024.1358597 (2024a).","journal-title":"Front. Microbiol."},{"key":"47296_CR12","doi-asserted-by":"publisher","unstructured":"Szklen\u00e1rik Gy, Kiraly, P., Szegvari, G., Dora, D. & Lohinai, Z. Predicting cancer-related mycobiome aspects in gastrointestinal cancers: a systematic review. Front. Med., 29 November 2024 Sec. Translational Medicine Volume 11\u20132024 https:\/\/doi.org\/10.3389\/fmed.2024.1488377","DOI":"10.3389\/fmed.2024.1488377"},{"key":"47296_CR13","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3390\/toxins14090596","volume":"14","author":"A Liu","year":"2022","unstructured":"Liu, A., Gao, W., Zhu, Y., Hou, X. & Chu, H. Gut non-bacterial microbiota: emerging link to irritable bowel syndrome. Toxins 14, 596. https:\/\/doi.org\/10.3390\/toxins14090596 (2022).","journal-title":"Toxins"},{"key":"47296_CR14","doi-asserted-by":"crossref","unstructured":"van Thiel, I., de Jonge, W. & n den Wijngaard, R. va Fungal feelings in the irritable bowel syndrome: the intestinal mycobiome and abdominal pain. Gut Microbes (2023).","DOI":"10.1080\/19490976.2023.2168992"},{"key":"47296_CR15","doi-asserted-by":"publisher","unstructured":":2168992. https:\/\/doi.org\/10.1080\/19490976.2023.2168992","DOI":"10.1080\/19490976.2023.2168992"},{"key":"47296_CR16","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.3389\/fmicb.2019.01894","volume":"10","author":"Y Gu","year":"2019","unstructured":"Gu, Y. et al. The potential role of gut Mycobiome in irritable bowel syndrome. Front. Microbiol. 10, 1894. https:\/\/doi.org\/10.3389\/fmicb.2019.01894 (2019).","journal-title":"Front. Microbiol."},{"key":"47296_CR17","doi-asserted-by":"publisher","first-page":"106807","DOI":"10.1016\/j.phrs.2023.106807","volume":"193","author":"L Wang","year":"2023","unstructured":"Wang, L. et al. Fan Gut mycobiome and metabolic diseases: The known, the unknown, and the future. Pharmacol. Res. 193, 106807. https:\/\/doi.org\/10.1016\/j.phrs.2023.106807 (2023).","journal-title":"Pharmacol. Res."},{"issue":"9","key":"47296_CR18","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1164\/rccm.202206-1066TR","volume":"207","author":"L Wang","year":"2023","unstructured":"Wang, L. et al. The Bidirectional Gut- Lung Axis in Chronic Obstructive Pulmonary Disease. Am. J. Respir Crit. Care Med. 207 (9), 1145\u20131160. https:\/\/doi.org\/10.1164\/rccm.202206-1066TR (2023). PMID: 36883945; PMCID: PMC10161745.","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"47296_CR19","doi-asserted-by":"publisher","unstructured":"Dora, D. et al. Metabolic pathways from the. gut metatranscriptome are associated with COPD and respiratory function in lung cancer patients. Front. Cell. Infect. Microbiol. 14, 1381170. https:\/\/doi.org\/10.3389\/fcimb.2024.1381170 (2024).","DOI":"10.3389\/fcimb.2024.1381170"},{"issue":"1","key":"47296_CR20","doi-asserted-by":"publisher","first-page":"2204746","DOI":"10.1080\/2162402X.2023.2204746","volume":"12","author":"D Dora","year":"2023","unstructured":"Dora, D. et al. Non-small cell lung cancer patients treated with Anti-PD1 immunotherapy show distinct microbial signatures and metabolic pathways according to progression-free survival and PD-L1 status. Oncoimmunology 12 (1), 2204746 (2023). PMID: 37197440; PMCID: PMC10184596.","journal-title":"Oncoimmunology"},{"issue":"1","key":"47296_CR21","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/s42003-025-08515-9","volume":"8","author":"L Mangnier","year":"2025","unstructured":"Mangnier, L. et al. A systematic benchmark of integrative strategies for microbiome-metabolome data. Commun. Biol. 8 (1), 1100. https:\/\/doi.org\/10.1038\/s42003-025-08515-9 (2025). PMID: 40707722; PMCID: PMC12289951.","journal-title":"Commun. Biol."},{"key":"47296_CR22","doi-asserted-by":"publisher","first-page":"27663","DOI":"10.3402\/mehd.v26.27663","volume":"26","author":"S Mandal","year":"2015","unstructured":"Mandal, S. et al. Analysis of composition of microbiomes: a novel method for studying microbial composition. Microb. Ecol. Health Dis. 26, 27663. https:\/\/doi.org\/10.3402\/mehd.v26.27663 (2015). PMID: 26028277; PMCID: PMC4450248.","journal-title":"Microb. Ecol. Health Dis."},{"issue":"1","key":"47296_CR23","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.1038\/s41467-020-17041-7","volume":"11","author":"H Lin","year":"2020","unstructured":"Lin, H. & Peddada, S. D. Analysis of compositions of microbiomes with bias correction. Nat. Commun. 11 (1), 3514. https:\/\/doi.org\/10.1038\/s41467-020-17041-7 (2020). PMID: 32665548; PMCID: PMC7360769.","journal-title":"Nat. Commun."},{"issue":"1","key":"47296_CR24","doi-asserted-by":"publisher","first-page":"iqae008","DOI":"10.1093\/oxfimm\/iqae008","volume":"5","author":"EA Sey","year":"2024","unstructured":"Sey, E. A. & Warris, A. The gut-lung axis: the impact of the gut mycobiome on pulmonary diseases and infections. Oxf. Open. Immunol. 5 (1), iqae008. https:\/\/doi.org\/10.1093\/oxfimm\/iqae008 (2024). PMID: 39193472; PMCID: PMC11316619.","journal-title":"Oxf. Open. Immunol."},{"key":"47296_CR25","doi-asserted-by":"publisher","first-page":"1407439","DOI":"10.3389\/fimmu.2024.1407439","volume":"15","author":"Z Kou","year":"2024","unstructured":"Kou, Z. et al. The alterations of oral, airway and intestine microbiota in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Front. Immunol. 15, 1407439 (2024). PMID: 38779669; PMCID: PMC11109405.","journal-title":"Front. Immunol."},{"issue":"1","key":"47296_CR26","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12931-021-01872-z","volume":"22","author":"N Li","year":"2021","unstructured":"Li, N. et al. Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease. Respir Res. 22 (1), 274. https:\/\/doi.org\/10.1186\/s12931-021-01872-z (2021). PMID: 34696775; PMCID: PMC8543848.","journal-title":"Respir Res."},{"issue":"4","key":"47296_CR27","doi-asserted-by":"publisher","first-page":"e0249944","DOI":"10.1371\/journal.pone.0249944","volume":"16","author":"YC Chiu","year":"2021","unstructured":"Chiu, Y. C. et al. Comprehensive profiling of the gut microbiota in patients with chronic obstructive pulmonary disease of varying severity. PLoS One. 16 (4), e0249944. https:\/\/doi.org\/10.1371\/journal.pone.0249944 (2021). PMID: 33836012; PMCID: PMC8034725.","journal-title":"PLoS One"},{"key":"47296_CR28","doi-asserted-by":"publisher","first-page":"175628482110471","DOI":"10.1177\/17562848211047130","volume":"14","author":"L Zhang","year":"2021","unstructured":"Zhang, L., Zhan, H., Xu, W., Yan, S. & Ng, S. C. The role of gut mycobiome in health and diseases. Th. Adv. Gastroenterol. 14, 17562848211047130. https:\/\/doi.org\/10.1177\/17562848211047130 (2021). PMID: 34589139; PMCID: PMC8474302.","journal-title":"Th. Adv. Gastroenterol."},{"key":"47296_CR29","doi-asserted-by":"publisher","unstructured":"Catal\u00e1n-Serra, I. et al. Fungal Microbiota Composition in Inflammatory Bowel Disease Patients: Characterization in Different Phenotypes and Correlation With Clinical Activity and Disease Course. Inflamm Bowel Dis. ;30(7):1164\u20131177. doi: 10.1093\/ibd\/izad289. Erratum in: Inflamm Bowel Dis. 2024 May 2;30(5):876. (2024). https:\/\/doi.org\/10.1093\/ibd\/izae070. PMID: 38103028; PMCID: PMC11219482.","DOI":"10.1093\/ibd\/izae070"},{"issue":"3","key":"47296_CR30","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.chom.2019.01.007","volume":"25","author":"JJ Limon","year":"2019","unstructured":"Limon, J. J. et al. Malassezia Is Associated with Crohn\u2019s Disease and Exacerbates Colitis in Mouse Models. Cell. Host Microbe. 25 (3), 377\u2013388e6 (2019). Epub 2019 Mar 5. PMID: 30850233; PMCID: PMC6417942.","journal-title":"Cell. Host Microbe"},{"issue":"6","key":"47296_CR31","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1136\/gutjnl-2015-310746","volume":"66","author":"H Sokol","year":"2017","unstructured":"Sokol, H. et al. Fungal microbiota dysbiosis in IBD. Gut 66 (6), 1039\u20131048. https:\/\/doi.org\/10.1136\/gutjnl-2015-310746 (2017). Epub 2016 Feb 3. PMID: 26843508; PMCID: PMC5532459.","journal-title":"Gut"},{"issue":"1","key":"47296_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s12916-023-03095-z","volume":"21","author":"Q Liu","year":"2023","unstructured":"Liu, Q. et al. Gut mycobiome as a potential non-invasive tool in early detection of lung adenocarcinoma: a cross-sectional study. BMC Med. 21 (1), 409. https:\/\/doi.org\/10.1186\/s12916-023-03095-z (2023). PMID: 37904139; PMCID: PMC10617124.","journal-title":"BMC Med."},{"key":"47296_CR33","doi-asserted-by":"publisher","unstructured":"Coyte, K. Z., Schluter, J. & Foster, K. R. The ecology of the microbiome: Networks, competition, and stability. Science. ;350(6261):663-6. (2015). https:\/\/doi.org\/10.1126\/science.aad2602. PMID: 26542567.","DOI":"10.1126\/science.aad2602"},{"key":"47296_CR34","doi-asserted-by":"publisher","first-page":"26087","DOI":"10.1038\/srep26087","volume":"6","author":"SN Baldassano","year":"2016","unstructured":"Baldassano, S. N. & Bassett, D. S. Topological distortion and reorganized modular structure of gut microbial co-occurrence networks in inflammatory bowel disease. Sci. Rep. 6, 26087. https:\/\/doi.org\/10.1038\/srep26087 (2016). PMID: 27188829; PMCID: PMC4870640.","journal-title":"Sci. Rep."},{"issue":"1","key":"47296_CR35","doi-asserted-by":"publisher","first-page":"4018","DOI":"10.1038\/s41467-020-17840-y","volume":"11","author":"L Chen","year":"2020","unstructured":"Chen, L. et al. Gut microbial co-abundance networks show specificity in inflammatory bowel disease and obesity. Nat. Commun. 11 (1), 4018. https:\/\/doi.org\/10.1038\/s41467-020-17840-y (2020). PMID: 32782301; PMCID: PMC7419557.","journal-title":"Nat. Commun."},{"issue":"6120","key":"47296_CR36","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1126\/science.1232467","volume":"339","author":"SE Winter","year":"2013","unstructured":"Winter, S. E. et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science 339 (6120), 708\u2013711. https:\/\/doi.org\/10.1126\/science.1232467 (2013). PMID: 23393266; PMCID: PMC4004111.","journal-title":"Science"},{"issue":"6351","key":"47296_CR37","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1126\/science.aam9949","volume":"357","author":"MX Byndloss","year":"2017","unstructured":"Byndloss, M. X. et al. Microbiota-activated PPAR-\u03b3 signaling inhibits dysbiotic Enterobacteriaceae expansion. Science 357 (6351), 570\u2013575. https:\/\/doi.org\/10.1126\/science.aam9949 (2017). PMID: 28798125; PMCID: PMC5642957.","journal-title":"Science"},{"key":"47296_CR38","doi-asserted-by":"publisher","unstructured":"Trompette, A. et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med. ;20(2):159\u2009\u2013\u200966. (2014). https:\/\/doi.org\/10.1038\/nm.3444. Epub 2014 Jan 5. PMID: 24390308.","DOI":"10.1038\/nm.3444"},{"issue":"6418","key":"47296_CR39","doi-asserted-by":"publisher","first-page":"eaat9076","DOI":"10.1126\/science.aat9076","volume":"362","author":"Y Litvak","year":"2018","unstructured":"Litvak, Y., Byndloss, M. X. & B\u00e4umler, A. J. Colonocyte metabolism shapes the gut microbiota. Science 362 (6418), eaat9076. https:\/\/doi.org\/10.1126\/science.aat9076 (2018). PMID: 30498100; PMCID: PMC6296223.","journal-title":"Science"},{"issue":"4","key":"47296_CR40","doi-asserted-by":"publisher","first-page":"e00648","DOI":"10.1128\/IAI.00648-20","volume":"89","author":"W Santus","year":"2021","unstructured":"Santus, W., Devlin, J. R. & Behnsen, J. Crossing Kingdoms: How the Mycobiota and Fungal-Bacterial Interactions Impact Host Health and Disease. Infect. Immun. 89 (4), e00648\u2013e00620. https:\/\/doi.org\/10.1128\/IAI.00648-20 (2021). PMID: 33526565; PMCID: PMC8090948.","journal-title":"Infect. Immun."},{"issue":"9","key":"47296_CR41","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3945\/jn.109.104638","volume":"139","author":"L Peng","year":"2009","unstructured":"Peng, L., Li, Z. R., Green, R. S., Holzman, I. R. & Lin, J. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J. Nutr. 139 (9), 1619\u20131625. https:\/\/doi.org\/10.3945\/jn.109.104638 (2009). Epub 2009 Jul 22. PMID: 19625695; PMCID: PMC2728689.","journal-title":"J. Nutr."},{"issue":"5","key":"47296_CR42","doi-asserted-by":"publisher","first-page":"e00645","DOI":"10.1128\/mSystems.00645-20","volume":"5","author":"SP Wang","year":"2020","unstructured":"Wang, S. P. et al. Pivotal Roles for pH, Lactate, and Lactate-Utilizing Bacteria in the Stability of a Human Colonic Microbial Ecosystem. mSystems 5 (5), e00645\u2013e00620. https:\/\/doi.org\/10.1128\/mSystems.00645-20 (2020). PMID: 32900872; PMCID: PMC7483512.","journal-title":"mSystems"},{"key":"47296_CR43","doi-asserted-by":"publisher","unstructured":"Dunagan, M., Chaudhry, K., Samak, G. & Rao, R. K. Acetaldehyde disrupts tight junctions in Caco-2 cell monolayers by a protein phosphatase 2A-dependent mechanism. Am J Physiol Gastrointest Liver Physiol. ;303(12):G1356-64. (2012). https:\/\/doi.org\/10.1152\/ajpgi.00526.2011. Epub 2012 Oct 11. Erratum in: Am J Physiol Gastrointest Liver Physiol. 2013 Jul 15;305(2):G204. PMID: 23064762; PMCID: PMC4073985.","DOI":"10.1152\/ajpgi.00526.2011"},{"issue":"6","key":"47296_CR44","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1159\/000522247","volume":"40","author":"H Faden","year":"2022","unstructured":"Faden, H. The Role of Faecalibacterium, Roseburia, and Butyrate in Inflammatory Bowel Disease. Dig. Dis. 40 (6), 793\u2013795 (2022). doi: 10.1159\/000522247. Epub 2022 Jan 27. PMID: 35168239.","journal-title":"Dig. Dis."},{"key":"47296_CR45","doi-asserted-by":"publisher","unstructured":"Tiew, P. Y. et al. A high-risk airway mycobiome is associated with frequent exacerbation and mortality in COPD. Eur Respir J. ;57(3):2002050. (2021). https:\/\/doi.org\/10.1183\/13993003.02050-2020. PMID: 32972986.","DOI":"10.1183\/13993003.02050-2020"},{"issue":"2","key":"47296_CR46","first-page":"134","volume":"14","author":"M Emami Ardestani","year":"2015","unstructured":"Emami Ardestani, M. & Zaerin, O. Role of Serum Interleukin 6, Albumin and C-Reactive Protein in COPD Patients. Tanaffos 14 (2), 134\u2013140 (2015). PMID: 26528368; PMCID: PMC4629428.","journal-title":"Tanaffos"},{"issue":"4","key":"47296_CR47","doi-asserted-by":"publisher","first-page":"361","DOI":"10.4168\/aair.2022.14.4.361","volume":"14","author":"J Ham","year":"2022","unstructured":"Ham, J., Kim, J., Ko, Y. G. & Kim, H. Y. The Dynamic Contribution of Neutrophils in the Chronic Respiratory Diseases. Allergy Asthma Immunol. Res. 14 (4), 361\u2013378. https:\/\/doi.org\/10.4168\/aair.2022.14.4.361 (2022). PMID: 35837821; PMCID: PMC9293600.","journal-title":"Allergy Asthma Immunol. Res."},{"issue":"1","key":"47296_CR48","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","volume":"24","author":"A Wahlstr\u00f6m","year":"2016","unstructured":"Wahlstr\u00f6m, A., Sayin, S. I., Marschall, H. U. & B\u00e4ckhed, F. Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism. Cell. Metab. 24 (1), 41\u201350. https:\/\/doi.org\/10.1016\/j.cmet.2016.05.005 (2016). Epub 2016 Jun 16. PMID: 27320064.","journal-title":"Cell. Metab."},{"key":"47296_CR49","doi-asserted-by":"publisher","unstructured":"Budden, K. F. et al. Emerging pathogenic links between microbiota and the gut-lung axis. Nat Rev Microbiol. ;15(1):55\u201363. (2017). https:\/\/doi.org\/10.1038\/nrmicro.2016.142. Epub 2016 Oct 3. PMID: 27694885.","DOI":"10.1038\/nrmicro.2016.142"},{"issue":"1","key":"47296_CR50","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s40168-020-00899-6","volume":"8","author":"B Seelbinder","year":"2020","unstructured":"Seelbinder, B. et al. Antibiotics create a shift from mutualism to competition in human gut communities with a longer-lasting impact on fungi than bacteria. Microbiome 8 (1), 133. https:\/\/doi.org\/10.1186\/s40168-020-00899-6 (2020). PMID: 32919472; PMCID: PMC7488854.","journal-title":"Microbiome"},{"issue":"1","key":"47296_CR51","doi-asserted-by":"publisher","first-page":"8872","DOI":"10.1038\/s41598-019-45467-7","volume":"9","author":"J Guinan","year":"2019","unstructured":"Guinan, J., Wang, S., Hazbun, T. R., Yadav, H. & Thangamani, S. Antibiotic-induced decreases in the levels of microbial-derived short-chain fatty acids correlate with increased gastrointestinal colonization of Candida albicans. Sci. Rep. 9 (1), 8872. https:\/\/doi.org\/10.1038\/s41598-019-45467-7 (2019). PMID: 31222159; PMCID: PMC6586901.","journal-title":"Sci. Rep."},{"key":"47296_CR52","doi-asserted-by":"publisher","unstructured":"Alsaeedi, A., Sin, D. D. & McAlister, F. A. The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials. Am J Med. ;113(1):59\u201365. (2002). https:\/\/doi.org\/10.1016\/s0002-9343(02)01143-9. PMID: 12106623.","DOI":"10.1016\/s0002-9343(02)01143-9"},{"key":"47296_CR53","doi-asserted-by":"publisher","unstructured":"Dang, A. T. & Marsland, B. J. Microbes, metabolites, and the gut-lung axis. Mucosal Immunol. ;12(4):843\u2013850. (2019). https:\/\/doi.org\/10.1038\/s41385-019-0160-6. Epub 2019 Apr 11. PMID: 30976087.","DOI":"10.1038\/s41385-019-0160-6"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47296-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47296-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47296-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:58:33Z","timestamp":1782863913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47296-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["47296"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-47296-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7992928\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors agree to submit the article for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"In the current study, we followed the principles of the Declaration of Helsinki established by the World Medical Association. The research protocol received formal approval from the national ethics authority, namely the Hungarian Scientific and Research Ethics Committee of the Medical Research Council (ETT TUKEB; approval number 50302-2\/2017\/EKU). All patients provided informed consent prior to participation. To ensure confidentiality, patient identifiers were removed after collecting clinicopathological data, thereby preventing both direct and indirect identification.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"20050"}}